Literature DB >> 16197301

Molecular targeting by homocysteine: a mechanism for vascular pathogenesis.

Donald W Jacobsen1, Otilia Catanescu, Patricia M Dibello, John C Barbato.   

Abstract

Hyperhomocysteinemia is an independent risk factor for cardiovascular disease. Although there is a growing body of evidence that homocysteine plays a causal role in atherogenesis, specific mechanisms to explain the underlying pathology have remained elusive. This review focuses on chemistry unique to the homocysteine molecule to explain its inherent cytotoxicity. Thus, the high pKa of the sulfhydryl group (pKa=10.0) of homocysteine underlies its ability to form stable disulfide bonds with protein cysteine residues, and in the process, alters or impairs the function of the protein. Albumin, fibronectin, transthyretin, annexin II, and factor V have now been identified as molecular targets for homocysteine, and in the case of albumin, the mechanism of targeting has been elucidated.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16197301     DOI: 10.1515/CCLM.2005.188

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  14 in total

1.  Incrimination of heterogeneous nuclear ribonucleoprotein E1 (hnRNP-E1) as a candidate sensor of physiological folate deficiency.

Authors:  Ying-Sheng Tang; Rehana A Khan; Yonghua Zhang; Suhong Xiao; Mu Wang; Deborah K Hansen; Hiremagalur N Jayaram; Aśok C Antony
Journal:  J Biol Chem       Date:  2011-09-19       Impact factor: 5.157

2.  Reference interval determination of total plasma homocysteine in an Indian population.

Authors:  Kapil D Lahiri; Himadri Datta; Harendra N Das
Journal:  Indian J Clin Biochem       Date:  2013-02-03

Review 3.  Mechanisms of cardiovascular remodeling in hyperhomocysteinemia.

Authors:  Mesia M Steed; Suresh C Tyagi
Journal:  Antioxid Redox Signal       Date:  2011-04-21       Impact factor: 8.401

4.  Hyperhomocysteinemia, as an independent risk factor for retinal venous occlusion in an Indian population.

Authors:  Kapil D Lahiri; Jayanta Dutta; Himadri Datta; Harendra N Das
Journal:  Indian J Clin Biochem       Date:  2012-07-04

Review 5.  Homocysteine-lowering interventions for preventing cardiovascular events.

Authors:  Arturo J Martí-Carvajal; Ivan Solà; Dimitrios Lathyris; Mark Dayer
Journal:  Cochrane Database Syst Rev       Date:  2017-08-17

Review 6.  Mechanisms of homocysteine-induced glomerular injury and sclerosis.

Authors:  Fan Yi; Pin-Lan Li
Journal:  Am J Nephrol       Date:  2007-11-07       Impact factor: 3.754

7.  Polymorphisms of the methylenetetrahydrofolate reductase, vascular endothelial growth factor, endothelial nitric oxide synthase, monocyte chemoattractant protein-1 and apolipoprotein E genes are not associated with carotid intima-media thickness.

Authors:  Emin Alioglu; Ugur Turk; Sirri Cam; Abbasali Abbasaliyev; Istemihan Tengiz; Ertugrul Ercan
Journal:  Can J Cardiol       Date:  2009-01       Impact factor: 5.223

8.  Age-associated perturbations in glutathione synthesis in mouse liver.

Authors:  Dikran Toroser; Rajindar S Sohal
Journal:  Biochem J       Date:  2007-08-01       Impact factor: 3.857

Review 9.  Homocysteine lowering interventions for preventing cardiovascular events.

Authors:  Arturo J Martí-Carvajal; Ivan Solà; Dimitrios Lathyris; Georgia Salanti
Journal:  Cochrane Database Syst Rev       Date:  2009-10-07

Review 10.  The therapeutic potential of cystathionine β-synthetase/hydrogen sulfide inhibition in cancer.

Authors:  Mark R Hellmich; Ciro Coletta; Celia Chao; Csaba Szabo
Journal:  Antioxid Redox Signal       Date:  2014-06-20       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.